Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoh Takekuma

Showing results (111-120 of 179) with videos related to

Pageof 18
Sort By:
Biological & Pharmaceutical Bulletin|March 3, 2020
Possibility for Dose Optimization of Pazopanib from Its Plasma Concentration in Japanese Patients with CancerHiroyuki Tanaka, Hiroaki Hiraga, Yoh Takekuma, et al.
European Journal of Clinical Pharmacology|January 30, 2023
Use of Japanese big data from electronic medical records to investigate risk factors and identify their high-risk combinations for linezolid-induced thrombocytopeniaYuki Inoue, Yoh Takekuma, Takayuki Miyai, et al.
Journal of Clinical Medicine|February 11, 2023
Prediction and Implications of Edoxaban-Associated Bleeding in Patients after Critical IllnessRyusei Mikami, Mineji Hayakawa, Shungo Imai, et al.
International Journal of Clinical Pharmacology and Therapeutics|March 3, 2024
Evaluation of the risk factors for the failure of a single prophylactic dose of anticholinergic drugs for irinotecan-induced cholinergic symptomsTakuya Watanabe, Yoshitaka Saito, Yoh Takekuma, et al.
Scientific Reports|January 19, 2026
Evaluating the potential to predict chemotherapy-induced nausea and vomiting in carboplatin-containing treatment based on symptoms induced by prior cisplatin-containing treatmentYoshitaka Saito, Takuya Watanabe, Yoh Takekuma, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 11, 2025
Younger age as a risk factor for rash development in pemetrexed and carboplatin treatment with dexamethasone prophylaxisYoshitaka Saito, Osamu Taniguchi, Yoh Takekuma, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 27, 2024
Impact of baseline renal impairment on severe neutropenia development in pemetrexed and carboplatin thoracic cancer treatmentYoshitaka Saito, Osamu Taniguchi, Yoh Takekuma, et al.
Clinical Transplantation|March 16, 2004
The variability of liver graft function and urinary 6beta-hydroxycortisol to cortisol ratio during liver regeneration in liver transplant recipientsSatoshi Kishino, Maki Ogawa, Yoh Takekuma, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|August 2, 2021
[Pharmaceutical Intervention According to Strict Management System Can Normalize Decreased Serum Calcium Level by Denosumab and Prevent Its Aggravation]Yoshitaka Saito, Kazuki Uchiyama, Tatsuhiko Sakamoto, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|May 15, 2007
Difference between pharmacokinetics of mycophenolic acid (MPA) in rats and that in humans is caused by different affinities of MRP2 to a glucuronized formYoh Takekuma, Haruka Kakiuchi, Koujiro Yamazaki, et al.
Pageof 18

Showing results (111-120 of 179) with videos related to

Sort By:
Pageof 18
Biological & Pharmaceutical Bulletin|March 3, 2020
Possibility for Dose Optimization of Pazopanib from Its Plasma Concentration in Japanese Patients with CancerHiroyuki Tanaka, Hiroaki Hiraga, Yoh Takekuma, et al.
European Journal of Clinical Pharmacology|January 30, 2023
Use of Japanese big data from electronic medical records to investigate risk factors and identify their high-risk combinations for linezolid-induced thrombocytopeniaYuki Inoue, Yoh Takekuma, Takayuki Miyai, et al.
Journal of Clinical Medicine|February 11, 2023
Prediction and Implications of Edoxaban-Associated Bleeding in Patients after Critical IllnessRyusei Mikami, Mineji Hayakawa, Shungo Imai, et al.
International Journal of Clinical Pharmacology and Therapeutics|March 3, 2024
Evaluation of the risk factors for the failure of a single prophylactic dose of anticholinergic drugs for irinotecan-induced cholinergic symptomsTakuya Watanabe, Yoshitaka Saito, Yoh Takekuma, et al.
Scientific Reports|January 19, 2026
Evaluating the potential to predict chemotherapy-induced nausea and vomiting in carboplatin-containing treatment based on symptoms induced by prior cisplatin-containing treatmentYoshitaka Saito, Takuya Watanabe, Yoh Takekuma, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 11, 2025
Younger age as a risk factor for rash development in pemetrexed and carboplatin treatment with dexamethasone prophylaxisYoshitaka Saito, Osamu Taniguchi, Yoh Takekuma, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 27, 2024
Impact of baseline renal impairment on severe neutropenia development in pemetrexed and carboplatin thoracic cancer treatmentYoshitaka Saito, Osamu Taniguchi, Yoh Takekuma, et al.
Clinical Transplantation|March 16, 2004
The variability of liver graft function and urinary 6beta-hydroxycortisol to cortisol ratio during liver regeneration in liver transplant recipientsSatoshi Kishino, Maki Ogawa, Yoh Takekuma, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|August 2, 2021
[Pharmaceutical Intervention According to Strict Management System Can Normalize Decreased Serum Calcium Level by Denosumab and Prevent Its Aggravation]Yoshitaka Saito, Kazuki Uchiyama, Tatsuhiko Sakamoto, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|May 15, 2007
Difference between pharmacokinetics of mycophenolic acid (MPA) in rats and that in humans is caused by different affinities of MRP2 to a glucuronized formYoh Takekuma, Haruka Kakiuchi, Koujiro Yamazaki, et al.
Pageof 18